Academic Clinical Cytogeneticist

The Department of Pathology at Beth Israel Deaconess Medical Center (BIDMC) is recruiting a

full-time Assistant Laboratory Director for its Cytogenetics Laboratory. Applicants must hold an MD, MD/PhD or PhD and be board certified in Clinical Cytogenetics and Molecular Genetics/Pathology. The position involves co-direction of a comprehensive cytogenetics laboratory including chromosome analysis, FISH, and chromosomal microarray on neoplastic and constitutional specimens.

Continuous development and implementation of new cutting-edge cytogenetic tests and technology platforms will be an important component of this position.

The Department of Pathology at BIDMC is in the process undertaking major expansion in Molecular Diagnostics, Digital Pathology, and Computational Pathology.

In addition, the Department of Pathology at BIDMC is engaged in the newly announced and exciting clinical alliance between BIDMC, Dana-Farber Cancer Institute (DFCI), and Harvard Medical Faculty Physicians (HMFP) to establish New England’s first and only free-standing adult inpatient cancer hospital, which will be a world-class facility of international visibility.

In addition to clinical and administrative responsibilities, the successful candidate will be expected to be active in pathology resident and fellow training as well as to develop a strong program in basic, applied, or translational research.

The candidate will be appointed to the

full-time faculty of Harvard Medical School at an academic rank commensurate with experience.

Candidates with existing strong extramurally funded research programs are encouraged to apply and will be supported by start-up support and research space.

Beth Israel Deaconess Medical Center is committed to

increasing representation by women and underrepresented minorities on its faculty, and we particularly encourage applications from such candidates.

About Us:

Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP) is one of the largest physician organizations in New England, dedicated to excellence and innovation in patient care, education, and research. As a physician-led organization, HMFP partners with more than 2,200 providers to support the delivery of exceptional care, promote professional development and diversity, and foster balance at work and home. HMFP physicians have faculty affiliations with Harvard Medical School (HMS) and provide care throughout the Beth Israel Lahey Health (BILH) system and additional hospitals across Massachusetts.

BIDMC is a tertiary care facility with 743 licensed beds and an internationally renowned principal teaching hospital of Harvard Medical School with

NCI Comprehensive Cancer Center-affiliated Cancer Center with strong and growing focus on solid tumor and hematologic malignancies. The collaboration will bring together world-class clinicians and scientists to deliver transformational precision medicine in an environment solely dedicated to defying cancer.

Beth Israel Deaconess Medical Center consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. Research funding totals over $229.8 million annually. BIDMC researchers run more than 850 active sponsored projects and 500 funded and non-funded clinical trials.

BIDMC also shares important clinical and research programs with institutions such as Harvard Medical School, MIT, the Broad Institute, Dana-Farber/Harvard Cancer Center, Joslin Diabetes Center, and Boston Children's Hospital.

BIDMC is a member of Beth Israel Lahey Health, a comprehensive academic health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, and more than 4,000 physicians and 35,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.

R0785